Add to ORKGObjectives Describe the current guidelines for CAT treatment. - Assess risk factors for bleeding and thrombosis in cancer patients and risk/benefits of anticoagulation. Recognize the need for individualized anticoagulation plans in order to make informed decisions that may differ from the guidelines. Propose anticoagulation in hospice if it will achieve the goals of the patient
Whilst the term cancer associated thrombosis (CAT) offers an overarching term for all thrombotic eve...
Introduction: Most of the current clinical guidelines recommend the use of Low-Molecular-Weight Hepa...
Background The treatment of cancer-associated thrombosis (CAT) is well established as a daily inject...
International audienceMany patients with cancer require palliative care at some stage and the vast m...
Background: Cancer associated venous thrombosis (CAT) can affect 20% of oncologic patients. Its mana...
Management of venous thromboembolism (VTE) in patients in advanced cancer can be difficult due to th...
Introduction: There is just few data available regarding the prophylaxis of thromboembolic disease ...
GOALS: The objective of this study was to determine utility of prophylactic anti-coagulation in canc...
Venous thromboembolism is common in patients with cancer. However, no management guidelines exist fo...
International audienceThere are no specific studies evaluating the benefit/risk of antithrombotic pr...
Cancer is a major risk factor for venous thromboembolism (VTE), and cancer-associated thrombosis (CA...
Whilst the term cancer associated thrombosis (CAT) offers an overarching term for all thrombotic eve...
Introduction: Most of the current clinical guidelines recommend the use of Low-Molecular-Weight Hepa...
Background The treatment of cancer-associated thrombosis (CAT) is well established as a daily inject...
International audienceMany patients with cancer require palliative care at some stage and the vast m...
Background: Cancer associated venous thrombosis (CAT) can affect 20% of oncologic patients. Its mana...
Management of venous thromboembolism (VTE) in patients in advanced cancer can be difficult due to th...
Introduction: There is just few data available regarding the prophylaxis of thromboembolic disease ...
GOALS: The objective of this study was to determine utility of prophylactic anti-coagulation in canc...
Venous thromboembolism is common in patients with cancer. However, no management guidelines exist fo...
International audienceThere are no specific studies evaluating the benefit/risk of antithrombotic pr...
Cancer is a major risk factor for venous thromboembolism (VTE), and cancer-associated thrombosis (CA...
Whilst the term cancer associated thrombosis (CAT) offers an overarching term for all thrombotic eve...
Introduction: Most of the current clinical guidelines recommend the use of Low-Molecular-Weight Hepa...
Background The treatment of cancer-associated thrombosis (CAT) is well established as a daily inject...